170 related articles for article (PubMed ID: 32511899)
1. Next-generation sequencing in residual liquid-based cytology specimens for cancer genome analysis.
Yamaguchi T; Akahane T; Harada O; Kato Y; Aimono E; Takei H; Tasaki T; Noguchi H; Nishihara H; Kamata H; Tanimoto A
Diagn Cytopathol; 2020 Nov; 48(11):965-971. PubMed ID: 32511899
[TBL] [Abstract][Full Text] [Related]
2. Direct next-generation sequencing analysis using endometrial liquid-based cytology specimens for rapid cancer genomic profiling.
Akahane T; Kitazono I; Kobayashi Y; Nishida-Kirita Y; Yamaguchi T; Yanazume S; Tabata K; Kobayashi H; Tanimoto A
Diagn Cytopathol; 2021 Sep; 49(9):1078-1085. PubMed ID: 34319014
[TBL] [Abstract][Full Text] [Related]
3. Sequential evaluation of MUC promoter methylation using next-generation sequencing-based custom-made panels in liquid-based cytology specimens of pancreatic cancer.
Yokoyama S; Iwaya H; Akahane T; Hamada T; Higashi M; Hashimoto S; Tanoue S; Ohtsuka T; Ido A; Tanimoto A
Diagn Cytopathol; 2022 Nov; 50(11):499-507. PubMed ID: 36181430
[TBL] [Abstract][Full Text] [Related]
4. K-ras mutation analysis of residual liquid-based cytology specimens from endoscopic ultrasound-guided fine needle aspiration improves cell block diagnosis of pancreatic ductal adenocarcinoma.
Sekita-Hatakeyama Y; Nishikawa T; Takeuchi M; Morita K; Takeda M; Hatakeyama K; Nakai T; Uchiyama T; Itami H; Fujii T; Mitoro A; Sho M; Ohbayashi C
PLoS One; 2018; 13(3):e0193692. PubMed ID: 29494669
[TBL] [Abstract][Full Text] [Related]
5. Evaluation and diagnostic value of next-generation sequencing analysis of residual liquid-based cytology specimens of pancreatic masses.
Sekita-Hatakeyama Y; Fujii T; Nishikawa T; Mitoro A; Sawai M; Itami H; Morita K; Uchiyama T; Takeda M; Sho M; Yoshiji H; Hatakeyama K; Ohbayashi C
Cancer Cytopathol; 2022 Mar; 130(3):202-214. PubMed ID: 34665935
[TBL] [Abstract][Full Text] [Related]
6. Using "residual" FNA rinse and body fluid specimens for next-generation sequencing: An institutional experience.
Wei S; Lieberman D; Morrissette JJ; Baloch ZW; Roth DB; McGrath C
Cancer Cytopathol; 2016 May; 124(5):324-9. PubMed ID: 26682952
[TBL] [Abstract][Full Text] [Related]
7. Feasibility of Endobronchial Ultrasound-guided Transbronchial Needle Aspiration Cytology Specimens for Next Generation Sequencing in Non-small-cell Lung Cancer.
Stoy SP; Segal JP; Mueller J; Furtado LV; Vokes EE; Patel JD; Murgu S
Clin Lung Cancer; 2018 May; 19(3):230-238.e2. PubMed ID: 29277564
[TBL] [Abstract][Full Text] [Related]
8. Next-Generation Sequencing Analysis of Pancreatic Cancer Using Residual Liquid Cytology Specimens from Endoscopic Ultrasound-Guided Fine-Needle Biopsy: A Prospective Comparative Study with Tissue Specimens.
Iwaya H; Tanimoto A; Toyodome K; Kojima I; Hinokuchi M; Tanoue S; Hashimoto S; Kawahira M; Arima S; Kanmura S; Akahane T; Higashi M; Suzuki S; Ueno S; Ohtsuka T; Ido A
Diagnostics (Basel); 2023 Mar; 13(6):. PubMed ID: 36980386
[TBL] [Abstract][Full Text] [Related]
9. Performance of a 50-gene next generation sequencing panel with post-centrifuge supernatant cytology fluid in non-small-cell lung cancer.
Tafoya M; Judd A; Chiotti K; Dearen K; Jiron K; Chabot-Richards D; Broehm CJ
Diagn Cytopathol; 2021 Nov; 49(11):1173-1178. PubMed ID: 34339108
[TBL] [Abstract][Full Text] [Related]
10. Cancer gene analysis of liquid-based cytology specimens using next-generation sequencing: A technical report of bimodal DNA- and RNA-based panel application.
Akahane T; Isochi-Yamaguchi T; Hashiba-Ohnuki N; Bandoh N; Aimono E; Kato Y; Nishihara H; Kamada H; Tanimoto A
Diagn Cytopathol; 2023 Aug; 51(8):493-500. PubMed ID: 37162026
[TBL] [Abstract][Full Text] [Related]
11. Targeted next generation sequencing of endoscopic ultrasound acquired cytology from ampullary and pancreatic adenocarcinoma has the potential to aid patient stratification for optimal therapy selection.
Gleeson FC; Kerr SE; Kipp BR; Voss JS; Minot DM; Tu ZJ; Henry MR; Graham RP; Vasmatzis G; Cheville JC; Lazaridis KN; Levy MJ
Oncotarget; 2016 Aug; 7(34):54526-54536. PubMed ID: 27203738
[TBL] [Abstract][Full Text] [Related]
12. Diff-Quik Cytology Smears from Endobronchial Ultrasound Transbronchial Needle Aspiration Lymph Node Specimens as a Source of DNA for Next-Generation Sequencing Instead of Cell Blocks.
Fielding D; Dalley AJ; Bashirzadeh F; Singh M; Nandakumar L; McCart Reed AE; Black D; Kazakoff S; Pearson JV; Nones K; Waddell N; Lakhani SR; Simpson PT
Respiration; 2019; 97(6):525-539. PubMed ID: 30731462
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of rapid on-site evaluation specimens from endoscopic ultrasound-guided fine-needle aspiration for cancer gene panel testing: A retrospective study.
Ishizawa T; Makino N; Matsuda A; Kakizaki Y; Kobayashi T; Ikeda C; Sugahara S; Tsunoda M; Ueno Y
PLoS One; 2020; 15(1):e0228565. PubMed ID: 31999789
[TBL] [Abstract][Full Text] [Related]
14. Young investigator challenge: Can the Ion AmpliSeq Cancer Hotspot Panel v2 be used for next-generation sequencing of thyroid FNA samples?
Bellevicine C; Sgariglia R; Malapelle U; Vigliar E; Nacchio M; Ciancia G; Eszlinger M; Paschke R; Troncone G
Cancer Cytopathol; 2016 Nov; 124(11):776-784. PubMed ID: 27717198
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive validation of liquid-based cytology specimens for next-generation sequencing in cancer genome analysis.
Akahane T; Yamaguchi T; Kato Y; Yokoyama S; Hamada T; Nishida Y; Higashi M; Nishihara H; Suzuki S; Ueno S; Tanimoto A
PLoS One; 2019; 14(6):e0217724. PubMed ID: 31199826
[TBL] [Abstract][Full Text] [Related]
16. Centrifuged supernatants from FNA provide a liquid biopsy option for clinical next-generation sequencing of thyroid nodules.
Ye W; Hannigan B; Zalles S; Mehrotra M; Barkoh BA; Williams MD; Cabanillas ME; Edeiken-Monroe B; Hu P; Duose D; Wistuba II; Medeiros LJ; Stewart J; Luthra R; Roy-Chowdhuri S
Cancer Cytopathol; 2019 Mar; 127(3):146-160. PubMed ID: 30620446
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic efficacy of liquid-based cytology for solid pancreatic lesion samples obtained with endoscopic ultrasound-guided fine-needle aspiration: Propensity score-matched analysis.
Hashimoto S; Taguchi H; Higashi M; Hatanaka K; Fujita T; Iwaya H; Nakazawa J; Arima S; Iwashita Y; Sasaki F; Nasu Y; Kanmura S; Ido A
Dig Endosc; 2017 Jul; 29(5):608-616. PubMed ID: 28160342
[TBL] [Abstract][Full Text] [Related]
18. Next-generation sequencing of liquid-based cytology non-small cell lung cancer samples.
Reynolds JP; Zhou Y; Jakubowski MA; Wang Z; Brainard JA; Klein RD; Farver CF; Almeida FA; Cheng YW
Cancer Cytopathol; 2017 Mar; 125(3):178-187. PubMed ID: 28085233
[TBL] [Abstract][Full Text] [Related]
19. FNA smears as a potential source of DNA for targeted next-generation sequencing of lung adenocarcinomas.
Treece AL; Montgomery ND; Patel NM; Civalier CJ; Dodd LG; Gulley ML; Booker JK; Weck KE
Cancer Cytopathol; 2016 Jun; 124(6):406-14. PubMed ID: 26882436
[TBL] [Abstract][Full Text] [Related]
20. BRAF (V600E) mutation analysis on liquid-based cytology-processed aspiration biopsies predicts bilaterality and lymph node involvement in papillary thyroid microcarcinoma.
Rossi ED; Martini M; Capodimonti S; Lombardi CP; Pontecorvi A; Vellone VG; Zannoni GF; Larocca LM; Fadda G
Cancer Cytopathol; 2013 Jun; 121(6):291-7. PubMed ID: 23192956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
